1. Home
  2. NVAX vs BTSG Comparison

NVAX vs BTSG Comparison

Compare NVAX & BTSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • BTSG
  • Stock Information
  • Founded
  • NVAX 1987
  • BTSG 1974
  • Country
  • NVAX United States
  • BTSG United States
  • Employees
  • NVAX N/A
  • BTSG N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • BTSG
  • Sector
  • NVAX Health Care
  • BTSG
  • Exchange
  • NVAX Nasdaq
  • BTSG NYSE
  • Market Cap
  • NVAX 2.0B
  • BTSG 2.0B
  • IPO Year
  • NVAX 1995
  • BTSG 2024
  • Fundamental
  • Price
  • NVAX $8.91
  • BTSG $19.57
  • Analyst Decision
  • NVAX Buy
  • BTSG Strong Buy
  • Analyst Count
  • NVAX 6
  • BTSG 12
  • Target Price
  • NVAX $17.83
  • BTSG $16.86
  • AVG Volume (30 Days)
  • NVAX 6.1M
  • BTSG 1.7M
  • Earning Date
  • NVAX 11-12-2024
  • BTSG 11-01-2024
  • Dividend Yield
  • NVAX N/A
  • BTSG N/A
  • EPS Growth
  • NVAX N/A
  • BTSG N/A
  • EPS
  • NVAX N/A
  • BTSG N/A
  • Revenue
  • NVAX $987,667,000.00
  • BTSG $10,588,215,000.00
  • Revenue This Year
  • NVAX N/A
  • BTSG $28.69
  • Revenue Next Year
  • NVAX N/A
  • BTSG $10.47
  • P/E Ratio
  • NVAX N/A
  • BTSG N/A
  • Revenue Growth
  • NVAX N/A
  • BTSG 25.72
  • 52 Week Low
  • NVAX $3.53
  • BTSG $7.85
  • 52 Week High
  • NVAX $23.86
  • BTSG $19.58
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 33.21
  • BTSG 77.60
  • Support Level
  • NVAX $8.43
  • BTSG $14.73
  • Resistance Level
  • NVAX $9.34
  • BTSG $17.54
  • Average True Range (ATR)
  • NVAX 0.49
  • BTSG 0.71
  • MACD
  • NVAX -0.04
  • BTSG 0.34
  • Stochastic Oscillator
  • NVAX 21.82
  • BTSG 99.79

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

About BTSG BRIGHTSPRING HEALTH SERVICES INC

BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Service. and others. It generates the majority of its revenue from the Pharmacy Solutions segment.

Share on Social Networks: